Skip to main content
BIOPHARMA CREDIT PLC logo

BIOPHARMA CREDIT PLC — Investor Relations & Filings

Ticker · BPCR ISIN · GB00BDGKMY29 LEI · 213800AV55PYXAS7SY24 IL Financial and insurance activities
Open in API
Filings indexed 731 across all filing types
Latest filing 2026-04-24 Net Asset Value
Country GB United Kingdom
Listing IL BPCR

About BIOPHARMA CREDIT PLC

https://bpcruk.com/

BioPharma Credit PLC is a specialist investment trust that provides debt capital to the life sciences industry. The company's primary objective is to generate long-term, sustainable income for shareholders by investing in a diversified portfolio of interest-bearing debt assets. These investments are typically secured by royalties, revenue streams, and other cash flows derived from approved pharmaceutical products and healthcare technologies. This strategy offers investors exposure to the life sciences sector through debt instruments while providing financing to companies for growth and development.

Recent filings

Filing Released Lang Actions
Net Asset Value(s) and Monthly Factsheet
Net Asset Value Classification · 94% confidence The document is an RNS release providing the unaudited net asset value per Ordinary Share as at 31 March 2026 and stating where the factsheet will be located. This is a routine NAV update rather than a full report or other announcement. Therefore it is classified as a Net Asset Value update (NAV).
2026-04-24 English
Dividend Declaration
Notice of Dividend Amount Classification · 92% confidence The document is an RNS announcement titled “DIVIDEND DECLARATION” by BioPharma Credit PLC detailing the interim dividend amount (1.75 cents per share), ex‐dividend date, record date, payment date, currency election, and other dividend logistics. This is clearly a Notice of Dividend Amount.
2026-04-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 92% confidence The document is an RNS announcement detailing the purchase of the company’s own shares into treasury, including number of shares, prices, and resulting share count. This clearly matches the definition of a Transaction in Own Shares (share repurchase) announcement.
2026-04-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 93% confidence The document is an RNS announcement titled “TRANSACTION IN OWN SHARES,” detailing the purchase of ordinary shares into treasury, quantities, prices, and resulting share counts. This matches the definition for share repurchase announcements under code POS.
2026-04-10 English
Investor Presentation via Investor Meet Company
Investor Presentation Classification · 88% confidence The document is an RNS announcement titled “Investor Presentation via Investor Meet Company.” It provides event details (date, time, how to register) for a live investor presentation, outlining that the company’s Investment Adviser will present the company’s strategy and portfolio. There is no full presentation file or transcript appended, so this is not the report itself but an announcement of an upcoming investor presentation. This corresponds to the “Investor Presentation” category (IP).
2026-04-10 English
Transaction in Own Shares
Transaction in Own Shares Classification · 92% confidence The document is an RNS announcement titled “TRANSACTION IN OWN SHARES,” detailing the purchase of the company’s own ordinary shares (quantity, price, treasury holdings, voting rights). This directly matches the Transaction in Own Shares category (POS).
2026-04-10 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.